Table 5.
Distribution of scores by dimension and for the total OHIP (mean ± SD)
| Before implant treatment | After implant treatment | p-value | |
|---|---|---|---|
| Q1 | 2.7 ± 1.2 | 2.0 ± 1.1 | 0.009* |
| Q2 | 2.1 ± 1.2 | 1.6 ± 1.0 | 0.141 |
| Q3 | 2.2 ± 1.0 | 1.8 ± 1.0 | 0.183 |
| Q4 | 3.6 ± 1.2 | 3.3 ± 1.4 | 0.490 |
| Q5 | 3.3 ± 1.2 | 2.8 ± 1.4 | 0.127 |
| Q6 | 2.9 ± 1.2 | 2.6 ± 1.2 | 0.176 |
| Q7 | 2.6 ± 1.2 | 2.1 ± 1.0 | 0.101 |
| Q8 | 2.4 ± 1.1 | 1.9 ± 0.9 | 0.048* |
| Q9 | 2.2 ± 1.1 | 1.9 ± 1.0 | 0.385 |
| Q10 | 3.0 ± 1.0 | 2.3 ± 1.1 | 0.003* |
| Q11 | 1.8 ± 1.0 | 1.4 ± 0.6 | 0.034* |
| Q12 | 1.8 ± 1.0 | 1.3 ± 0.6 | 0.016* |
| Q13 | 2.5 ± 1.2 | 1.8 ± 0.9 | 0.006* |
| Q14 | 1.6 ± 0.8 | 1.3 ± 0.6 | 0.036* |
| Overall OHIP score | 34.6 ± 11.4 | 28.2 ± 9.7 | 0.020* |
*p < 0.05 compared to the scores before implant treatment by Mann–Whitney U test